Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study

PurposeThis study aimed to characterize the safety profiles of rivaroxaban-associated suspected adverse events by mining the Food and Drug Administration Adverse Event Reporting System (FAERS).MethodsA disproportionality analysis of spontaneously reported suspected adverse drug reactions (ADRs) was...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Jingying Wu, Jianru Wu, Biyu Tang, Xinru Wang, Fenfang Wei, Yi Zhang, Limin Li, Hongqiao Li, Bei Wang, Wenyu Wu, Xiang Hong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	suspected adverse event disproportionality analysis drug safety pharmacovigilance rivaroxaban
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1399172/full